Abstract
The synthesis of a series of differently substituted 8-chloro-benzo[c]quinolizin-3-ones, as potent and selective human steroid 5alpha-reductase type 1 inhibitors, has been accomplished by a four-step procedure based on the TiCl4-promoted tandem Mannich-Michael cyclization of 2-silyloxy-1,3-butadienes with N-t-Boc iminium ions from quinolin-2-ones. The presence on the benzo[c]quinolizinone nucleus of a methyl group and a double bond at positions 6 and 4-4a, respectively, as in compound 1d, gave rise to one of the most potent non-steroidal 5alphaR-1 inhibitors reported so far (IC50 = 14 nM).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
3-Oxo-5-alpha-Steroid 4-Dehydrogenase / metabolism
-
5-alpha Reductase Inhibitors*
-
Anti-Inflammatory Agents, Non-Steroidal / chemical synthesis
-
Anti-Inflammatory Agents, Non-Steroidal / chemistry
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Inhibitory Concentration 50
-
Quinolizines / chemical synthesis
-
Quinolizines / chemistry*
-
Quinolizines / pharmacology*
-
Quinolones / chemistry
-
Quinolones / pharmacology
-
Sensitivity and Specificity
-
Structure-Activity Relationship
-
Titanium / metabolism
Substances
-
5-alpha Reductase Inhibitors
-
Anti-Inflammatory Agents, Non-Steroidal
-
Enzyme Inhibitors
-
Quinolizines
-
Quinolones
-
8-chloro-4-methyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolin-3(2H)-one
-
titanium tetrachloride
-
Titanium
-
3-Oxo-5-alpha-Steroid 4-Dehydrogenase